About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID 		Tg(FES-cre)31Bsl
transgene insertion 31, Monica Bessler
MGI:2386125
Summary 3 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
 		Pigatm1Tak/Pigatm1Tak
Tg(FES-cre)31Bsl/0 		involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA/Ca MGI:6304006
cn2
 		Pigatm1Bsl/Piga+
Tg(FES-cre)31Bsl/0 		involves: 129S1/Sv * C57BL/6 * CBA/Ca MGI:3814205
cn3
 		Pigatm1Bsl/Y
Tg(FES-cre)31Bsl/0 		involves: 129S1/Sv * C57BL/6 * CBA/Ca MGI:3814206


Genotype
MGI:6304006
cn1
Allelic
Composition		 Pigatm1Tak/Pigatm1Tak
Tg(FES-cre)31Bsl/0
Genetic
Background		 involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA/Ca
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pigatm1Tak mutation (1 available); any Piga mutation (3 available)
Tg(FES-cre)31Bsl mutation (0 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
hematopoietic system
abnormal T cell morphology ( J:162065 )
• mice show the appearance of clonally-restricted, inactive yet functionally competent CD8 T cells, with an enrichment of CD8 T cells that lack glycosyl phosphatidylinositol (GPI) and GPI-anchored proteins in the blood, marrow, and spleen and enrichment of GPI- CD4 T cells in the spleen, and with pronounced Vbeta5.1/5.2 skewing of GPI- T cells
• however, mice do not show bone marrow failure, autoimmunity, or hemoglobinuria despite reduced immunosuppressive Treg cells
decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number ( J:162065 )
• the proportion of CD4+CD25+FoxP3+ regulatory T cells is lower in peripheral blood
• however, there are no differences in the proportion of natural killer T cells in peripheral blood
abnormal T cell physiology ( J:162065 )
• mice exhibit fewer GPI- gamma-interferon producing CD8 T and CD4 T cells after lectin stimulation with myristate acetate and ionomycin
abnormal T cell activation ( J:162065 )
• marker analysis indicates that the enlarged pool of GPI- CD8 T cells is less activated than normal T cells

immune system
abnormal T cell morphology ( J:162065 )
• mice show the appearance of clonally-restricted, inactive yet functionally competent CD8 T cells, with an enrichment of CD8 T cells that lack glycosyl phosphatidylinositol (GPI) and GPI-anchored proteins in the blood, marrow, and spleen and enrichment of GPI- CD4 T cells in the spleen, and with pronounced Vbeta5.1/5.2 skewing of GPI- T cells
• however, mice do not show bone marrow failure, autoimmunity, or hemoglobinuria despite reduced immunosuppressive Treg cells
decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number ( J:162065 )
• the proportion of CD4+CD25+FoxP3+ regulatory T cells is lower in peripheral blood
• however, there are no differences in the proportion of natural killer T cells in peripheral blood
abnormal T cell physiology ( J:162065 )
• mice exhibit fewer GPI- gamma-interferon producing CD8 T and CD4 T cells after lectin stimulation with myristate acetate and ionomycin
abnormal T cell activation ( J:162065 )
• marker analysis indicates that the enlarged pool of GPI- CD8 T cells is less activated than normal T cells




Genotype
MGI:3814205
cn2
Allelic
Composition		 Pigatm1Bsl/Piga+
Tg(FES-cre)31Bsl/0
Genetic
Background		 involves: 129S1/Sv * C57BL/6 * CBA/Ca
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pigatm1Bsl mutation (0 available); any Piga mutation (3 available)
Tg(FES-cre)31Bsl mutation (0 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
growth/size/body
weight loss ( J:71354 )
• developing around 12 months of age

behavior/neurological
weakness ( J:71354 )
• general muscular weakness after 12 months of age
decreased locomotor activity ( J:71354 )
• decreased overall activity after 12 months of age

neoplasm
increased hemangioma incidence ( J:71354 )
• sometimes seen in spleen and lymph nodes at 12 months of age
increased B cell derived lymphoma incidence ( J:71354 )
• sometimes seen in spleen and lymph nodes at 12 months of age




Genotype
MGI:3814206
cn3
Allelic
Composition		 Pigatm1Bsl/Y
Tg(FES-cre)31Bsl/0
Genetic
Background		 involves: 129S1/Sv * C57BL/6 * CBA/Ca
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pigatm1Bsl mutation (0 available); any Piga mutation (3 available)
Tg(FES-cre)31Bsl mutation (0 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
growth/size/body
weight loss ( J:71354 )
• developing around 12 months of age

behavior/neurological
weakness ( J:71354 )
• general muscular weakness after 12 months of age
abnormal gait ( J:71354 )
• wide gait in males only, after 12 months of age
decreased locomotor activity ( J:71354 )
• decreased overall activity after 12 months of age

neoplasm
increased hemangioma incidence ( J:71354 )
• sometimes seen in spleen and lymph nodes at 12 months of age
increased B cell derived lymphoma incidence ( J:71354 )
• sometimes seen in spleen and lymph nodes at 12 months of age




Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
07/02/2024
MGI 6.13 		The Jackson Laboratory